Loading...
XNAS
BNKK
Market cap155mUSD
Jul 09, Last price  
1.28USD
1D
-2.29%
1Q
-52.06%
IPO
-78.67%
Name

Jupiter Wellness Inc

Chart & Performance

D1W1MN
XNAS:BNKK chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
-11.37%
Rev. gr., 5y
155.44%
Revenues
0k
6,4551,065,6652,876,2736,196,743202,67000
Net income
-68m
-932,019-6,406,007-29,836,351-17,671,484-15,083,0410-68,185,762
CFO
-25m
L+39.72%
-692,740-2,732,736-7,567,645-6,395,942-10,113,777-18,089,748-25,275,735

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jupiter Wellness, Inc. specializes in the development of therapeutic and wellness products derived from cannabidiol (CBD). Its clinical development portfolio features several innovative candidates, such as CaniDermRX (JW-100), a unique topical blend of CBD and aspartame aimed at addressing eczema, dermatitis, and actinic keratosis. Also in development are JW-101, a prescription solution designed for burn treatment, and JW-200, an over-the-counter lotion or lip balm formulated to alleviate symptoms associated with cold sores. Beyond its clinical efforts, Jupiter Wellness also manufactures, distributes, and markets a range of consumer goods. These include CBD-enriched sunscreens sold under the CaniSun label, CBD-infused skincare lotions marketed as CaniSkin, and a selection of dermatological remedies for pain and inflammation offered through its CaniDermRX brand. Established in 2018, the company, formerly known as CBD Brands, Inc., maintains its headquarters in Jupiter, Florida.
IPO date
Oct 22, 2020
Employees
10
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT